Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2015 Feb 16;2015:372630. doi: 10.1155/2015/372630

Corrigendum to “Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells”

Anahita Rahmani 1, Danial Kheradmand 2, Peyman Keyhanvar 3,4, Alireza Shoae-Hassani 1, Amir Darbandi-Azar 4,*
PMCID: PMC4345232  PMID: 25785267

In ‘‘Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells,” there was an error in Figure  4(a), and here we provide the right form of Figure  4(a).

Figure 4.

Figure 4

Immunostaining of hEnSCs differential markers. Expression of neuron markers including Nestin, MAP-2, and β-tubulin was analyzed in FLX induced differentiation after 10 d. The expression of CD11b as a glial marker was not obvious. The size bar is 10 μm (a). Immunostaining of LY294002 treated hEnSCs after culture in FLX supplemented medium. There is not an expression of neuron markers in FLX induced differentiation after 10 d (b).


Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES